KZR (kezarlifesciences.com) שווי פעילות לנפח מכירות

Kezar Life Sciences' high authority in immunology, driven by innovative inhibitors, determines the dynamics captured in the enterprise value-to-revenue ratio on the GURU.Markets analytical chart. A diverse pipeline in rare niches and selective therapies for skin and kidney diseases mitigate risks, while the 0.00 metric confirms the current business valuation relative to its debt-free sales.
KZR (Kezar Life Sciences, Inc): פילוחים אנליטיים ודוחות לפי אינדיקטורים

For long-term risk control, it is critical to monitor asset overvaluation, which is reflected by the EV/Sales valuation multiple that compares the Enterprise Value to annual revenue. The current value of 0.00 accounts for the capital intensity of the cold chain delivery for Kezar Life Sciences (KZR) immunological drugs, allowing investors to assess the company's market value adjusted for debt relative to its ability to generate revenue.